Home
Team
Portfolio
About us
News & Insights
Meet Us
Talent
Contact
NEWS & INSIGHTS
Latest from us and the industry leaders of tomorrow
Filter
News
Insights
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
20 Jan 2025
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment
News
09 Jan 2025
AnaCardio raises USD 19 million to advance first-in-class drug candidate AC01 for heart failure
News
13 Nov 2024
Calliditas Therapeutics: A Case Study of Strategic Investment and Successful Exit by Industrifonden
News
20 Sep 2024
Jonathan Ilicki, Principal at Industrifonden, Selected for Obama Leaders Europe Program
News
16 Sep 2024
Cellevate closes second seed round, raising 3.2 MEUR to enter into global commercialization
News
10 Sep 2024
Industrifonden Celebrates Successful Exit as Calliditas Therapeutics is Acquired by Asahi Kasei
News
29 Aug 2024
SaltX Technology appoints Lina Jorheden as acting CEO and strengthens its financial position with additional funding
News
27 Aug 2024
Industrifonden leads SEK 15 million investment round in BrainZell – pioneering the future of medicine for neurological diseases
News
13 Mar 2024
SaltX secures SEK 38 million and enters partnership with ABB
Previous
Next PAGE
WE'RE SWEDEN'S
Venture capital fund
FAQ
Privacy Policy
Linkedin
Newsletter
Industrifonden
Vasagatan 11
PO Box 1163
111 91 Stockholm
Sweden
Get directions
Phone: +46 8 587 919 00
E-mail: info@industrifonden.com
ⓒ 2026 Industrifonden